Logo image of TEVA

TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Analyst Ratings

NYSE:TEVA - New York Stock Exchange, Inc. - US8816242098 - ADR - Currency: USD

16.04  -0.38 (-2.31%)

After market: 16.0799 +0.04 (+0.25%)

Buy % Consensus

42

ChartMill assigns a Buy % Consensus number of 42% to TEVA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.05. This target is -99.68% below the current price.
TEVA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about TEVA.
In the previous month the buy percentage consensus was at a similar level.
TEVA was analyzed by 9 analysts. More opinions would make the average more meaningful.
TEVA Historical Analyst RatingsTEVA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 16.040.050.050.050.05 - -99.68% -99.68% -99.68% -99.67%
TEVA Current Analyst RatingTEVA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-06-26 UBS Maintains Buy -> Buy
2025-06-06 Goldman Sachs Initiate Buy
2025-05-28 Truist Securities Initiate Buy
2025-05-12 JP Morgan Upgrade Neutral -> Overweight
2025-05-08 B of A Securities Maintains Buy -> Buy
2025-03-06 B of A Securities Maintains Buy -> Buy
2025-01-30 UBS Maintains Buy -> Buy
2025-01-30 Barclays Maintains Overweight -> Overweight
2025-01-23 UBS Maintains Buy -> Buy
2025-01-17 Piper Sandler Maintains Overweight -> Overweight
2024-12-18 Barclays Maintains Overweight -> Overweight
2024-10-23 Barclays Maintains Overweight -> Overweight
2024-10-21 JP Morgan Maintains Neutral -> Neutral
2024-09-03 UBS Maintains Buy -> Buy
2024-08-01 Barclays Maintains Overweight -> Overweight
2024-07-10 UBS Maintains Buy -> Buy
2024-06-27 Jefferies Maintains Buy -> Buy
2024-06-05 Barclays Maintains Overweight -> Overweight
2024-05-30 B of A Securities Maintains Buy -> Buy
2024-05-13 Piper Sandler Reiterate Overweight -> Overweight
2024-05-09 Barclays Maintains Overweight -> Overweight
2024-03-08 JP Morgan Upgrade Underweight -> Neutral
2024-02-12 Piper Sandler Upgrade Neutral -> Overweight
2024-02-05 Barclays Maintains Overweight -> Overweight
2024-02-05 Goldman Sachs Maintains Neutral -> Neutral
2024-01-29 Barclays Maintains Overweight -> Overweight
2024-01-23 Jefferies Upgrade Hold -> Buy
2024-01-03 Piper Sandler Upgrade Underweight -> Neutral
2023-12-18 HSBC Initiate Buy
2023-11-27 UBS Upgrade Neutral -> Buy